ICU Management & Practice, ICU Volume 7 - Issue 3 - Autumn 2007

A judgment was awarded to Johns Hopkins University and Arrow International, Inc. in their patent infringement lawsuit against Datascope Corp. on Friday, June 15, 2007, in the United States District Court in Baltimore, Maryland. Johns Hopkins and Arrow had brought suit against Datascope for infringing patents relating to the Arrow-TrerotolaTM Percutaneous Thrombolytic Device (PTD®), a device used by interventionalists for treating haemodialysis patients. The Baltimore jury found that the Datascope ProLumen device infringed three patents owned by Johns Hopkins and licensed by Arrow, and upheld their validity. The jury also awarded damages amounting to an 18% royalty on Datascope’s sales of the infringing device. Johns Hopkins and Arrow have asked the court to issue a permanent injunction against Datascope's sales of the ProLumen.


www.arrowintl.com

«« New ‘Robust’ Treatment for Stroke Uses Genetic Material From Bone Marrow


Your Eyes May Hold Clues to Stroke Risk »»